Why big pharma may be​​ doomed

KEY THOUGHT: Pharma companies three on meetings. According to an article in MIT’s Sloan Management Review, the average manager spends 23 hours a week in meetings, up a whopping 10 full hours (!) since the Mad Men era. Some of those meetings are no doubt productive but conservatively at least a third of the time spent on meetings is wasted in irrelevant conversations, boring presentations, and meandering chit-chat.

Continue reading

What’s important to pharma CEOs?

KEY THOUGHT: According to the Times “We’re in a world where we need leaders to improve the state of the world, not just the state of the bottom line,” Marc Benioff, the co-chief executive of Salesforce, said in an interview. “Every C.E.O. has this on their mind right now.” Does this apply to pharma CEOs?

Continue reading